日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer

阿特珠单抗联合FOLFOX方案治疗III期错配修复缺陷型结肠癌

Sinicrope, Frank A; Ou, Fang-Shu; Arnold, Dirk; Peters, Walter R; Behrens, Robert J; Lieu, Christopher H; Matin, Khalid; Cohen, Deirdre J; Potter, Samara L; Nixon, Andrew B; Kottschade, Lisa A; Kathol, Emily; Frankel, Wendy L; Shergill, Ardaman; Hsu, Dennis; Reinacher-Schick, Anke; Mehan, Paul; Gold, Philip J; Khalil, Maged F; Zemla, Tyler; Gatten, Clare; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease

人群对代谢功能障碍相关脂肪肝疾病筛查的益处和危害的看法

Allen, Alina M; Kim, W Ray; Carrieri, Patrizia; Canning, Rachel; Ou, Fang-Shu; Benson, Joanne; Olson, Jessica L; Venkatesh, Sudhakar K; Li, Jiahui; Yin, Meng; Eslami, Maysa; Ehman, Richard L; Hunter Berg, Jennifer; Lazarus, Jeffrey V

Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602)

卡博替尼治疗晚期 3 级神经内分泌肿瘤:3 期 CABINET 试验(Alliance A021602)的亚组分析

Strosberg, Jonathan R; Zemla, Tyler; Geyer, Susan; Pulsipher, Sydney; Ou, Fang-Shu; Behr, Spencer; Raj, Nitya; Vijayvergia, Namrata; Dasari, Arvind; O'Reilly, Eileen M; Meyerhardt, Jeffrey A; Wolin, Edward M; Halfdanarson, Thorvardur R; Chan, Jennifer A

ARID4B Promotes Lung Adenocarcinoma Malignancy by Activating GPRC5C transcription via Histone H1 Displacement

ARID4B通过组蛋白H1置换激活GPRC5C转录,从而促进肺腺癌恶性进展

Huang, Guangnan; Gao, Lei; Fang, Shu; Xu, Likun; Zhao, Xiaowei

The segmented flavivirus ALSV-encoded nucleoprotein VP2 inhibits type I interferon production by targeting RIG-I.

节段黄病毒ALSV编码的核蛋白VP2通过靶向RIG-I抑制I型干扰素的产生。

Pan Mingming, Song Zhixia, Wang Mengmeng, Zhao Mengru, Fang Shu, Jin Fangyu, Tan Qianqian, Xu Wenbo, Che Lihe, Liu Nan, Sui Liyan, Liu Quan, Hou Zhijun, Zhao Yinghua

Perceived stigma, emotional resilience, and depressive/anxiety symptoms across school stages: a cross-sectional study

感知到的污名、情绪韧性和抑郁/焦虑症状在不同学段阶段的变化:一项横断面研究

Fang, Shu-Ping; Luo, Jian-Jun; Wang, Cong; Liu, Yi-Hao; Yang, Yi-Yue; Zhou, Lie; Jin, Hui; Xiao, Yun; Wen, Yang; Ahmad, Jawad; Wang, Wei; Cai, Jia; Tian, Qian-Qian; Jiang, Guo-Qing; Ran, Mao-Sheng

TONSL promotes hepatocellular carcinoma progression and radioresistance by orchestrating DNA damage repair and cell cycle dynamics

TONSL通过调控DNA损伤修复和细胞周期动力学,促进肝细胞癌的进展和放射抗性。

Luo, Min-Rui; Liao, Jia-Lin; Fang, Shu-Jie; Zhang, Dong-Yan; Lei, Ling

Clonorchis sinensis and cholangiocarcinoma: molecular mechanisms and biomarker advances

中华肝吸虫与胆管癌:分子机制和生物标志物进展

Huang, Chenlin; Wu, Yinjuan; Wu, Aoxun; Huang, Linya; Fang, Shu; Xu, Chunyan; Liu, Tianhao; Li, Yichen; Li, Xuerong

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

卡博替尼治疗晚期神经内分泌肿瘤的3期临床试验

Chan, Jennifer A; Geyer, Susan; Zemla, Tyler; Knopp, Michael V; Behr, Spencer; Pulsipher, Sydney; Ou, Fang-Shu; Dueck, Amylou C; Acoba, Jared; Shergill, Ardaman; Wolin, Edward M; Halfdanarson, Thorvardur R; Konda, Bhavana; Trikalinos, Nikolaos A; Tawfik, Bernard; Raj, Nitya; Shaheen, Shagufta; Vijayvergia, Namrata; Dasari, Arvind; Strosberg, Jonathan R; Kohn, Elise C; Kulke, Matthew H; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

The PKCι-β-arrestin2 axis disrupts SORLA retrograde trafficking, driving its degradation and amyloid pathology in Alzheimer's disease.

PKCα-β-arrestin2 轴会破坏 SORLA 的逆向运输,从而导致其降解和阿尔茨海默病中的淀粉样蛋白病理

Rehman Hasibur, Yan Shun, Saggu Shalini, Aida Mae, Zhang Fang, Shu Yang, Jones Alexis, Trang Amy, Dew Emily, Zhi Wenbo, Claeboe Emily T, Baucum Anthony J 2nd, Wu Guangyu, Jiao Kai, Wang Qin